Biblio Discovery — Demo Discovery Service

3 hasil untuk "Lin, L."

Menampilkan 1–3 · 0,46 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Dose-Dependent Mutation Rates Determine Optimum Erlotinib Dosing Strategies for EGFR Mutant Non-Small Cell Lung Cancer Patients

    Lin L. Liu; Fei Li; William Pao dkk.

    PLOS ONE, Vol. 10 No. 11 · 2015 · Inggris · PLOS Scopus

    Background: The advent of targeted therapy for cancer treatment has brought about a paradigm shift in the clinical management of human malignancies. Agents such as erlotinib used for EGFR-mutant non-small cell lung cancer or imatinib for chronic myeloid leukemia, for instance, lead to rapid tumor…

  2. Artikel Jurnal Teks lengkap

    An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer

    Jasmine Foo; Lin L Liu; Kevin Leder dkk.

    PLOS Computational Biology, Vol. 11 No. 9 · 2015 · Inggris · PLOS Scopus

    The traditional view of cancer as a genetic disease that can successfully be treated with drugs targeting mutant onco-proteins has motivated whole-genome sequencing efforts in many human cancer types. However, only a subset of mutations found within the genomic landscape of cancer is likely to…

  3. Artikel Jurnal Teks lengkap

    Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies

    Kimiyo N. Yamamoto; Akira Nakamura; Lin L. Liu dkk.

    PLOS ONE, Vol. 14 No. 4 · 2019 · Inggris · PLOS Scopus

    Pancreatic ductal adenocarcinoma (PDAC) exhibits a variety of phenotypes with regard to disease progression and treatment response. This variability complicates clinical decision-making despite the improvement of survival due to the recent introduction of FOLFIRINOX (FFX) and nab-paclitaxel…